Equities researchers at Pivotal Research started coverage on shares of Crocs, Inc. (NASDAQ:CROX) in a research note issued on Thursday, MarketBeat reports. The brokerage set a “hold” rating and a $9.50 price target on the textile maker’s stock. Pivotal Research’s price objective indicates a potential downside of 1.55% from the stock’s previous close.

Several other analysts have also recently issued reports on CROX. ValuEngine cut Crocs from a “hold” rating to a “sell” rating in a research report on Friday, September 1st. BidaskClub cut Crocs from a “buy” rating to a “hold” rating in a research report on Thursday, August 24th. Zacks Investment Research upgraded Crocs from a “hold” rating to a “buy” rating and set a $10.00 target price for the company in a research report on Monday, August 14th. Susquehanna Bancshares Inc reiterated a “positive” rating and set a $8.00 target price (up previously from $7.00) on shares of Crocs in a research report on Thursday, August 10th. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $9.00 target price on shares of Crocs in a research report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $8.75.

Crocs (NASDAQ CROX) traded down 0.52% on Thursday, reaching $9.65. The company’s stock had a trading volume of 618,267 shares. The stock has a 50-day moving average of $9.17 and a 200-day moving average of $7.61. The stock’s market cap is $692.49 million. Crocs has a one year low of $5.93 and a one year high of $9.90.

Crocs (NASDAQ:CROX) last posted its quarterly earnings data on Wednesday, August 9th. The textile maker reported $0.27 EPS for the quarter, topping the consensus estimate of $0.15 by $0.12. Crocs had a negative return on equity of 3.36% and a negative net margin of 0.91%. The firm had revenue of $313.20 million for the quarter, compared to the consensus estimate of $311.33 million. During the same quarter last year, the company earned $0.16 earnings per share. The business’s revenue for the quarter was down 3.3% compared to the same quarter last year. On average, analysts predict that Crocs will post ($0.03) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Crocs, Inc. (CROX) Now Covered by Pivotal Research” was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/10/05/crocs-inc-crox-now-covered-by-pivotal-research.html.

Several large investors have recently added to or reduced their stakes in CROX. Ameriprise Financial Inc. grew its holdings in Crocs by 1.5% during the 1st quarter. Ameriprise Financial Inc. now owns 1,003,918 shares of the textile maker’s stock valued at $7,097,000 after buying an additional 15,030 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in Crocs by 60.8% during the 2nd quarter. Russell Investments Group Ltd. now owns 270,775 shares of the textile maker’s stock valued at $2,088,000 after buying an additional 102,378 shares in the last quarter. Great West Life Assurance Co. Can grew its holdings in Crocs by 7.4% during the 1st quarter. Great West Life Assurance Co. Can now owns 106,681 shares of the textile maker’s stock valued at $754,000 after buying an additional 7,353 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Crocs by 53.1% during the 1st quarter. Renaissance Technologies LLC now owns 2,127,636 shares of the textile maker’s stock valued at $15,042,000 after buying an additional 737,636 shares in the last quarter. Finally, Morgan Stanley grew its holdings in Crocs by 37.6% during the 1st quarter. Morgan Stanley now owns 1,327,853 shares of the textile maker’s stock valued at $9,388,000 after buying an additional 362,712 shares in the last quarter. Hedge funds and other institutional investors own 88.56% of the company’s stock.

About Crocs

Crocs, Inc is engaged in the design, development, manufacturing, marketing, distribution and sale of casual lifestyle footwear and accessories for men, women, and children. The Company’s segments include Americas, Asia Pacific and Europe. Its products include footwear and accessories that utilize its closed-cell resin, called Croslite, as well as casual lifestyle footwear that use a range of materials.

Analyst Recommendations for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.